$2.27
-0.08-3.40%
Last update: 10:02 AM
15 minutes delayed
Comments
Loading...
Cocrystal Pharma
COCPNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Cocrystal Pharma (NASDAQ:COCP) Stock, Analyst Ratings, Price Targets, Forecasts
Cocrystal Pharma Inc has a consensus price target of $10 based on the ratings of 1 analysts. The high is $10 issued by HC Wainwright & Co. on May 14, 2024. The low is $10 issued by HC Wainwright & Co. on May 14, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on May 14, 2024, April 4, 2024, and March 20, 2024, respectively. With an average price target of $10 between HC Wainwright & Co., there's an implied 340.53% upside for Cocrystal Pharma Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Cocrystal Pharma
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/14/2024 | Buy Now | 340.53% | HC Wainwright & Co. | Raghuram Selvaraju | — | Reiterates | Buy → Buy | Get Alert |
| 04/04/2024 | Buy Now | 340.53% | HC Wainwright & Co. | Raghuram Selvaraju | → $10 | Reiterates | Buy → Buy | Get Alert |
| 03/20/2024 | Buy Now | 340.53% | HC Wainwright & Co. | Raghuram Selvaraju | → $10 | Reiterates | Buy → Buy | Get Alert |
| 01/03/2024 | Buy Now | 340.53% | HC Wainwright & Co. | Raghuram Selvaraju | $12 → $10 | Maintains | Buy | Get Alert |
| 12/04/2023 | Buy Now | 428.63% | HC Wainwright & Co. | Raghuram Selvaraju | → $12 | Reiterates | Buy → Buy | Get Alert |
| 10/04/2023 | Buy Now | 428.63% | HC Wainwright & Co. | Raghuram Selvaraju | → $12 | Reiterates | Buy → Buy | Get Alert |
| 08/15/2023 | Buy Now | 428.63% | HC Wainwright & Co. | Raghuram Selvaraju | → $12 | Reiterates | Buy → Buy | Get Alert |
| 08/11/2023 | Buy Now | 428.63% | HC Wainwright & Co. | Raghuram Selvaraju | → $12 | Reiterates | Buy → Buy | Get Alert |
| 06/02/2023 | Buy Now | 428.63% | HC Wainwright & Co. | Raghuram Selvaraju | → $12 | Reiterates | Buy → Buy | Get Alert |
| 05/24/2023 | Buy Now | 428.63% | HC Wainwright & Co. | Raghuram Selvaraju | $35 → $12 | Maintains | Buy | Get Alert |
| 01/24/2023 | Buy Now | 1441.85% | HC Wainwright & Co. | Raghuram Selvaraju | $42 → $35 | Maintains | Buy | Get Alert |
| 11/07/2022 | Buy Now | 1750.22% | HC Wainwright & Co. | Raghuram Selvaraju | $4 → $42 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Cocrystal Pharma (COCP) stock?
The latest price target for Cocrystal Pharma (NASDAQ:COCP) was reported by HC Wainwright & Co. on May 14, 2024. The analyst firm set a price target for $10.00 expecting COCP to rise to within 12 months (a possible 340.53% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cocrystal Pharma (COCP)?
The latest analyst rating for Cocrystal Pharma (NASDAQ:COCP) was provided by HC Wainwright & Co., and Cocrystal Pharma reiterated their buy rating.
When was the last upgrade for Cocrystal Pharma (COCP)?
There is no last upgrade for Cocrystal Pharma
When was the last downgrade for Cocrystal Pharma (COCP)?
There is no last downgrade for Cocrystal Pharma.
When is the next analyst rating going to be posted or updated for Cocrystal Pharma (COCP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cocrystal Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cocrystal Pharma was filed on May 14, 2024 so you should expect the next rating to be made available sometime around May 14, 2025.
Is the Analyst Rating Cocrystal Pharma (COCP) correct?
While ratings are subjective and will change, the latest Cocrystal Pharma (COCP) rating was a reiterated with a price target of $10.00 to $10.00. The current price Cocrystal Pharma (COCP) is trading at is $2.27, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.